Normal view MARC view ISBD view

Lipid-Based Nano-Delivery for Oral Administration of Atazanavir: Design, Optimization and Characterization

By:

Material type: Film

FilmPublication details: Ahmedabad Institute of Pharmacy, Nirma University 2020Description: 78pSubject(s):

DDC classification:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode	Item holds
Dissertation	NIMA Knowledge Centre	Reference	615.19 SEV (Browse shelf(Opens below))	Not For Loan		PDR00601
CD/DVD	NIMA Knowledge Centre	Reference	615.19 SEV (Browse shelf(Opens below))	Not For Loan		PDR00601-1

Total holds: 0

Previous	No cover image available	No cover image available	No cover image available	No cover image available		No cover image available	No cover image available	Next
Previous	615.19 SET Evaluation of Molecular Subtypes in Breast Cancer Patients and Its Correlation with Other Clinical Attributes and Treatment in Ahmedabad Region of India and Determination of Stress Levels in University Faculty	615.19 SET Evaluation of Molecular Subtypes in Breast Cancer Patients and Its Correlation with Other Clinical Attributes and Treatment in Ahmedabad Region of India and Determination of Stress Levels in University Faculty	615.19 SEV Lipid-Based Nano-Delivery for Oral Administration of Atazanavir: Design, Optimization and Characterization	615.19 SEV Lipid-Based Nano-Delivery for Oral Administration of Atazanavir: Design, Optimization and Characterization	615.19 SHA Practical Pharmaceutical Chemistry (II) and Viva Voce for Diploma and Pharmacy and B Pharmacy Students	615.19 SHA Computer Aided Drug Designing, Synthesis and Pharmacological Evaluation of Quinazoline-4-one Moiety as AMPA Receptor Non-Competitive Antagonist	615.19 SHA Computer Aided Drug Designing, Synthesis and Pharmacological Evaluation of Quinazoline-4-one Moiety as AMPA Receptor Non-Competitive Antagonist	Next

Guided by Dr. Shital Butani

There are no comments on this title.

to post a comment.